Rapid Drugs Screening Test Kit
- UID
- MFG/IVD/2022/000123_4b50fb5bd651d1014888e68a7589d638_75439fcef915a7e0969c12431072ca8d
- Device class
- Class C
- Brand name
- including H5N1 and H1N1
- License holder
- PARAMCARE LIFE SCIENCES PRIVATE LIMITED
- Approving authority
- Central Drug Standards Control Organization, Ahmedabad
- Product information
- The Rapid Drugs (including H5N1 and H1N1) Screening Test Kit is a rapid test that qualitatively detects the presence of Cannabinoids in human urine specimen at the cut off value of 50 ng/mL. The test utilizes a combination of monoclonal antibody and BSA conjugated Cannabinoids to detect Cannabinoids in human urine sample
Rapid Drugs Screening Test Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2022/000123_4b50fb5bd651d1014888e68a7589d638_75439fcef915a7e0969c12431072ca8d. This device is marketed under the brand name including H5N1 and H1N1. The license holder is PARAMCARE LIFE SCIENCES PRIVATE LIMITED, and it is classified as Device Class Class C. The approving authority is Central Drug Standards Control Organization, Ahmedabad.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.